-
8961por Hong, Yun Soo, Chang, Yoosoo, Ryu, Seungho, Cainzos-Achirica, Miguel, Kwon, Min-Jung, Zhang, Yiyi, Choi, Yuni, Ahn, Jiin, Rampal, Sanjay, Zhao, Di, Pastor-Barriuso, Roberto, Lazo, Mariana, Shin, Hocheol, Cho, Juhee, Guallar, Eliseo“…The corresponding odds ratio comparing hepatitis C antibodies (HCV Ab) (+) to HCV Ab (−) participants was 1.43 (95% CI 1.01–2.02, P = 0.043). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8962por Stafford, Kristen A., Rikhtegaran Tehrani, Zahra, Saadat, Saman, Ebadi, Maryam, Redfield, Robert R., Sajadi, Mohammad M.“…To estimate the effect of hepatitis C virus (HCV) coinfection on the development of complications and progression of human immunodeficiency virus (HIV) disease among HIV-infected elite controllers. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8963por Liu, Zhenhua, Wang, Song, Qi, Wenqian, Wang, Xu, Sun, Derong, Wang, Hongguang, Zhang, Yonggui, Li, Zhongxie, Zhu, Liying, Zhao, Ping, Guo, Honghua, Zhou, Changyu, Wang, Jiangbin“…This prospective study investigated the relationship between 2 inosine triphosphatase (ITPA) polymorphisms (rs7270101 and rs1127354) and the efficacy of ribavirin-based antiviral therapy in hepatitis C virus (HCV)-infected Chinese patients. A total of 906 patients diagnosed with chronic hepatitis C receiving pegylated interferon (PEG-IFN) plus ribavirin combination therapy between January 2011 and January 2014 from 5 hepatitis centers in Northeast China were enrolled. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8964por Nagaoki, Yuko, Imamura, Michio, Aikata, Hiroshi, Daijo, Kana, Teraoka, Yuji, Honda, Fumi, Nakamura, Yuki, Hatooka, Masahiro, Morio, Reona, Morio, Kei, Kan, Hiromi, Fujino, Hatsue, Kobayashi, Tomoki, Masaki, Keiichi, Ono, Atsushi, Nakahara, Takashi, Kawaoka, Tomokazu, Tsuge, Masataka, Hiramatsu, Akira, Kawakami, Yoshiiku, Hayes, C. Nelson, Miki, Daiki, Ochi, Hidenori, Chayama, Kazuaki“…The risk of hepatocellular carcinoma (HCC) development is reduced following viral elimination by interferon therapy in chronic hepatitis C patients. However, the risk in patients treated with interferon-free direct-acting antivirals (DAAs) is unknown. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8965por Pogorzelska, Joanna, Łapińska, Magda, Kalinowska, Alicja, Łapiński, Tadeusz W., Flisiak, Robert“…PATIENTS AND METHODS: The study included 147 patients with liver cirrhosis: 42 were infected with hepatitis C virus, 31 were infected with hepatitis B virus, 56 had alcoholic liver cirrhosis, and 18 had primary biliary cirrhosis. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8966por Amaku, Marcos, Burattini, Marcelo Nascimento, Chaib, Eleazar, Coutinho, Francisco Antonio Bezerra, Greenhalgh, David, Lopez, Luis Fernandez, Massad, Eduardo“…The model assumes incomplete notification of incidence and allows the estimation of the non-notified number of infections and it is illustrated by the case of hepatitis C in Brazil. The method has the advantage that it can be corrected iteratively by comparing its findings with empirical results. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8967por Ndjoyi-Mbiguino, Angélique, Kombe Kombe, Arnaud John, Bivigou-Mboumba, Berthold, Zoa-Assoumou, Samira, Akombi, Falone Larissa, Nzengui Nzengui, Francis, M’boyis Kamdem, Hervé, François-Souquière, Sandrine“…BACKGROUND: Gabon is an endemic area for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) and the risk of co-infection is high. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8968por Aldridge, Robert W, Hayward, Andrew C, Hemming, Sara, Yates, Susan K, Ferenando, Gloria, Possas, Lucia, Garber, Elizabeth, Watson, John M, Geretti, Anna Maria, McHugh, Timothy Daniel, Lipman, Marc, Story, Alistair“…Prevalence of current hepatitis C infection was 10.4% (51/489; 95% CI 7.8 to 13.1). …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8969por Yambasu, Emmanuel Edmond, Reid, Anthony, Owiti, Philip, Manzi, Marcel, Murray, Mariama Jeanne Sia, Edwin, Ama Kyerewaa“…Overall prevalence was: 9.7% hepatitis B; 1.0% hepatitis C; 2.8% HIV; 0.8% syphilis. Prevalence was higher among samples from rural blood banks, the difference most marked for hepatitis C. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8970por Carter, Chris J.“…APOE4 is concentrated in regions of high parasitic burden and protects against childhood tropical infections and hepatitis C. Immune/inflammatory gain of function applies to APOE4, CR1, and TREM2 variants. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8971por Ho, Shu-Yein, Liu, Po-Hong, Hsu, Chia-Yang, Hsia, Cheng-Yuan, Su, Chien-Wei, He, Yi-Jhen, Lee, Yun-Hsuan, Huang, Yi-Hsiang, Hou, Ming-Chih, Huo, Teh-Ia“…Low platelet count, prolonged prothrombin time, hepatitis C and multiple tumors were independently associated with advanced fibrosis. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8972“…Most of the patient had Child class 'B' cirrhosis 102(51%), most common etiology was found to be Hepatitis C 133 (66.5%), cholelithiasis was found in 59(29.5%), sludge in 36 (18%) and both stone and sludge in 24(12%) of the cases. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8973por Tachi, Yoshihiko, Hirai, Takanori, Kojima, Yuko, Ishizu, Yoji, Honda, Takashi, Kuzuya, Teiji, Hayashi, Kazuhiko, Ishigami, Masatoshi, Goto, Hidemi“…BACKGROUND AND AIM: Predictive factors for hepatocarcinogenesis following eradication of hepatitis C virus by direct‐acting antivirals (DAAs) are unknown. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8974por Corsi, Gabriela, Wanger, Audrey, James, Karen, Banner, Brian, Patel, Bela, Katz, Jeffrey, Ostrosky-Zeichner, Luis“…RESULTS: During the study period, a total of 512 HIV viral loads, 29 HIV genotypes, and 58 Hepatitis C genotypes were ordered. The total expense on the HIV viral load tests was $43,228, total expense on HIV genotypes was $8,669, and for Hepatitis C genotype was $43,055. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8975“…Up to 2016, only 3 million hepatitis C cases have been treated. Pricing of hepatitis C virus drugs is also reduced in many countries. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8976por Arif, Tooba“…INTRODUCTION: Hepatitis B is a vaccine-preventable disease, and hepatitis C is amenable to treatment. Both are highly prevalent in the prison population. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8977“…BACKGROUND: Hepatitis B virus and hepatitis C virus infections are a public health problem worldwide. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8978por Maughan, A., Sadigh, K., Angulo-Diaz, V., Mandimika, C., Villanueva, M., Lim, J. K., Ogbuagu, O.“…BACKGROUND: Treatments for Hepatitis C virus (HCV) infection have vastly improved over the past few decades with current regimens now offering pangenotypic activity with excellent cure rates reported in clinical trials, including in the HIV-HCV coinfected population. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8979por Bielen, Rob, Koc, Özgür M, Busschots, Dana, Robaeys, Geert, Aertgeerts, Bert, Vaes, Bert, Mamouris, Pavlos, Mathei, Catharina, Goderis, Geert, Nevens, Frederik“…OBJECTIVES: Chronic infections with hepatitis B virus (HBV) and hepatitis C virus (HCV) have a major impact on mortality worldwide. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
8980por Kawaguchi, Takumi, Komori, Atsumasa, Fujisaki, Kunio, Nishiguchi, Shuhei, Kato, Michio, Takagi, Hitoshi, Tanaka, Yasuhito, Notsumata, Kazuo, Mita, Eiji, Nomura, Hideyuki, Shibatoge, Mitsushige, Takaguchi, Koichi, Hattori, Toshihiro, Sata, Michio, Koike, Kazuhiko“…To investigate the efficacy of eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C, a phase II, single-arm, open-label study with a 9-week pre-antiviral phase was conducted, followed by a 48-week antiviral phase and a 24-week follow-up phase. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto